Algen Biotechnologies Is A Biotechnology Company Focused On Functional Genomics And Ai Driven Drug Discoveryfounded In 2018It Emerged From The Uc Berkeley Laboratory Of Nobel Laureate Jennifer Doudnathe Company Aims To Develop Therapeutics For Cancers And Inflammatory Diseases By Utilizing Crispr Based Gene Modulationsingle Cell Analysisand Deep Learning Techniques Algen Biotechnologies Offers Innovative Platforms Such As Algencrisprwhich Enables Precise Gene Modulationand Algenbraina Decision Support Tool That Integrates Gene Modulation Data With Ai Modelsthe Company Collaborates With Pharmaceutical Partners To Enhance Therapeutic Discoverytargeting High Unmet Need Diseasesits Pipeline Includes A Preclinical Stage Development Candidate And Additional Drug Programsall Aimed At Addressing Complex Health Challenges
United States
